Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Characterization of Tigecycline Non-Susceptibility among Extensively Drug-Resistant Acinetobacter baumannii Isolates of Clinical Origin.

Chemotherapy - 1 Jan 2021

Haeili Mehri, Abdollahi Ali, Ahmadi Amin, Khoshbayan Amin

Abstract excerpt

INTRODUCTION: Tigecycline (TGC) is one of the last-resort therapeutic agents for treating infections caused by extensively drug resistant Acinetobacter baumannii isolates. Although resistance to TGC is not common, non-susceptible A. baumannii (NSAB) isolates have been described. In the current study, we aimed to assess the molecular mechanisms mediating TGC non-susceptibility in 5 clinical isolates of A....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acinetobacter baumannii
Share to Acinetobacter Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Anti-Bacterial Agents

Share to ATP-Binding Cassette Transporters

Share to Drug Resistance, Multiple, Bacterial

Share to Microbial Sensitivity Tests

Share to Tigecycline

Share to Transcription, Genetic

Source

Identifiers

PMID: 33823517
DOI: 10.1159/000515100

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Characterization of Tigecycline Non-Susceptibility among Extensively Drug-Resistant Acinetobacter baumannii Isolates of Clinical Origin.PMID 33823517Read ↗

Molecular Epidemiology and Mechanisms of Tigecycline Resistance in Clinical Isolates of Acinetobacter baumannii from a Chinese University HospitalSemantic proximity Read ↗

Comparison of antimicrobial activities and resistance mechanisms of eravacycline and tigecycline against clinical Acinetobacter baumannii isolates in ChinaSemantic proximity Read ↗

Genome analysis of tigecycline-resistant Acinetobacter baumannii reveals nosocomial lineage shifts and novel resistance mechanisms.Semantic proximity Read ↗

Mechanisms of Resistance, Clonal Expansion, and Increasing Prevalence of Acinetobacter baumannii Strains Displaying Elevated Tigecycline MIC Values in Latin America.Semantic proximity Read ↗

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).Semantic proximity Read ↗

Resistance associated genomic variations for moderate level tigecycline resistance evolution in Acinetobacter baumannii.Semantic proximity Read ↗

Role of efflux pumps in reduced susceptibility to tigecycline in Acinetobacter baumanniiSemantic proximity Read ↗

Correlation of RND efflux pump expression and AdeRS mutations in tigecycline-resistant Acinetobacter baumannii from Thai clinical isolatesSemantic proximity Read ↗

Characterization of Tigecycline Resistance Among Tigecycline Non-susceptible Klebsiella pneumoniae Isolates From Humans, Food-Producing Animals, and in vitro Selection AssaySemantic proximity Read ↗

Genetic diversity and characteristics of high-level tigecycline resistance Tet(X) in Acinetobacter species.Semantic proximity Read ↗

The Mechanism of Tigecycline Resistance in Acinetobacter baumannii under Sub-Minimal Inhibitory Concentrations of TigecyclineSemantic proximity Read ↗

Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumanniiSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.